A recombinant protein of the human T cell lymphotropic virus type I (HTLV-I) gp46 outer
membrane envelope, MTA-4 (residues 129–203), reacted by Western blot with sera from …

Disease association studies of human T cell lymphotropic virus (HTLV) types I and II are
hindered by the need for multiple assays to confirm and differentiate between the viruses. A …

An immunodominant HTLV-I-specific epitope in the HTLV-I envelope glycoprotein (GP) 46
has been described. To determine if the analogous region of HTLV-II contains a similarly …

The identification and isolation ofunique and immunogenic recombinant epitopes for human
T celllymphotrophic virus (HTLV) type I might allow the development of an antibody-based …

The major internal structural protein of human T-cell lymphotropic virus type III (HTLV-III), a
virus etiologically implicated in acquired immunodeficiency syndrome (AIDS), was purified to …

The confirmation of infection with human T-cell lymphotropic virus type I (HTLV-I) and type II
(HTLV-II) currently involves multiple assays. These include Western blot (immunoblot)(WB) …

Synthetic peptide‐based serologic assays (Select‐HTLV and SynthEIA) that distinguish the
closely related human T‐cell lymphotropic virus types I (HTLV‐I) and II (HTLV‐II) were tested …

Eighteen long-term T-cell lines were established from peripheral blood mononuclear cells of
individuals infected with human T-lymphotropic virus type I (HTLV-I) or II (HTLV-II). These …

Synthetic peptides corresponding with unique regions of the envelope glycoproteins (gp46)
of human T cell Iymphotropic viruses (HTLVs) were used in an enzyme immunoassay to …

The heterogeneity of immune responsiveness to the immunodominant epitopes of human T
lymphotropic virus (HTLV) types I (MTA-1162–209) and II (K-55162–205) were determined …